Results 81 to 90 of about 15,418 (233)
Ten years since the last Chikungunya virus outbreak in Italy. History repeats itself [PDF]
The prevalence of Arbovirus (arthropod-borne virus) infections is increasing worldwide. Recently, new clusters of autochthonous cases have been reported in countries with temperate climates where the competent vector is present.
Franchini, Massimo +7 more
core +1 more source
Chikungunya virus (CHIKV) is the causative agent of Chikungunya fever, an acute febrile and arthritogenic illness with no effective treatments available. The development of effective therapeutic strategies could be significantly accelerated with detailed
Marjorie C. L. C. Freire +16 more
doaj +1 more source
Chikungunya virus-induced autophagy delays caspase-dependent cell death [PDF]
Autophagy is an important survival pathway and can participate in the host response to infection. Studying Chikungunya virus (CHIKV), the causative agent of a major epidemic in India, Southeast Asia, and southern Europe, we reveal a novel mechanism by ...
Alessandra Giodini +84 more
core +2 more sources
Novel Wide‐Spectrum Virucidal Lipid Nanoparticles
POSTAN is a novel broad‐spectrum antiviral nanoparticle that combines safety with potent virucidal activity. Composed of biocompatible lipids, it mimics heparan sulfate proteoglycans and lipid rafts exploited by viruses, thereby dismantling viral envelopes and blocking replication.
Yugo Araújo Martins +10 more
wiley +1 more source
Antiviral activity of silymarin against chikungunya virus [PDF]
Citation: Lani, R., Hassandarvish, P., Chiam, C. W., Moghaddam, E., Chu, J. J. H., Rausalu, K., . . . Zandi, K. (2015). Antiviral activity of silymarin against chikungunya virus. Scientific Reports, 5, 10.
Abu Bakar, S. +10 more
core +1 more source
Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil, 2019–2021
Abstract Background and Objectives Arbovirus infections are a major public health concern in Brazil and an ongoing blood safety concern. Periodic outbreaks of such infections are common in the general population. This study aimed to establish the rates of dengue, chikungunya and Zika virus (DENV, CHIKV, ZIKV) RNAemia among blood donors at six public ...
Eduard Grebe +18 more
wiley +1 more source
HLA class I restriction as a possible driving force for Chikungunya evolution.
After two decades of quiescence, epidemic resurgence of Chikungunya fever (CHIKF) was reported in Africa, several islands in the Indian Ocean, South-East Asia and the Pacific causing unprecedented morbidity with some cases of fatality. Early phylogenetic
Joo Chuan Tong +4 more
doaj +1 more source
Chikungunya virus (CHIKV) is a re-emerging mosquito-borne human pathogen that causes chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological evidence indicated that CHIKV first emerged in 1954. From the 1950’s to 2005,
Sarawut Khongwichit +3 more
doaj +1 more source
Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light [PDF]
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that recently re-emerged in Africa and rapidly spread into countries of the Indian Ocean basin and South-East Asia.
Higgs, Stephen +5 more
core +1 more source
This review explores nanoparticle (NP)‐based biosensors and nanovaccine platforms for arboviral infections, highlighting their design, performance, and translational potential. By comparing case studies across viruses, it identifies gold‐standard nanomaterials such as gold NPs (AuNPs), zinc oxide NPs (ZnONPs), molybdenum disulfide (MoS2) nanocomposites,
Peyman Halvaeikhanekahdani +3 more
wiley +1 more source

